What's New

Pegfilgrastim-cbqv (Udenyca®)

Pegfilgrastim-cbqv (Udenyca®) is a type of colony stimulating factor, which is a group of medications that stimulate the production and function of blood cells, including white blood cells, red blood cells and platelets. 

Trastuzumab-qyyp (Trazimera™)

Trastuzumab-qyyp (Trazimera™) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancer.

Tagraxofusp-erzs (Elzonris™)

Tagraxofusp-erzs (Elzonris™) is a chemotherapy used in the treatment of some types of blastic plasmacytoid dendritic cell neoplasm. 


OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

You Don’t Know the New Me
by OncoLink Team
Jun 25, 2019

Survivorship Care Plans – What does the future hold?
by Carolyn Vachani, MSN, RN, AOCN
Jun 24, 2019

Cancer Survivor’s Day/Month
by OncoLink Team
Jun 20, 2019

View all Blogs

Cancer Awareness

National Cancer Survivors Day

The first Sunday in June celebrates National Cancer Survivor’s Day. With over 13 million survivors in the US alone, there is a lot to celebrate! Learn more about cancer survivorship, watch the Navigating Life After Cancer webinar or create your own OncoLife Care Plan to celebrate your favorite survivor.

Need Cancer Patient Education Tools?

Our award winning cancer education content is now available for licensing and syndication.

I Wish U Knew!

I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.